Immunofluorescence staining

ZL Zhiping Li
XJ Xuanmao Jiao
GS Gabriele Di Sante
AE Adam Ertel
MC Mathew C. Casimiro
MW Min Wang
SK Sanjay Katiyar
XJ Xiaoming Ju
DK D. V. Klopfenstein
AT Aydin Tozeren
WD William Dampier
IC Iouri Chepelev
AJ Albert Jeltsch
RP Richard G. Pestell
request Request a Protocol
ask Ask a question
Favorite

Immunofluorescence staining was conducted as described previously [56]. The cells in four-well chamber slides were fixed for 10 min at room temperature (RT) with 4% paraformaldehyde, and subsequently with cold methanol at −20 °C for 5 min. The slides were then treated with 0.2% Triton X-100 for 5 min at RT and blocked with 2% bovine serum albumin overnight at 4 °C. For H3K9me2 and cyclin D1, G9a and cyclin D1 co-staining in MEFs the primary antibodies used were mouse monoclonal anti-H3K9me2 (ab1220) (Abcam Inc.) (1/800), mouse monoclonal anti-G9a (clonal A8620A) (PP-A8620A-00) (R&D System) (1/500), and rabbit polyclonal anti-cyclin D1 (clone H-295) (sc-753) (Santa Cruz Biotechnology, Santa Cruz, CA) (1/200). The secondary antibodies used were Alexa Fluor 568-conjugated goat anti-mouse immunoglobulin G (IgG) (Molecular Probes, Inc.) (1/500) and Alexa Fluor 647-conjugated F(ab′)2 fragment of goat anti-rabbit IgG (Molecular Probes, Inc.) (1/500). For HT1080 immunostaining the primary antibodies used were mouse monoclonal anti-cyclin D1 (clone DCS-6) (sc-20044) (Santa Cruz Biotechnology, Santa Cruz, CA) (1/200), rabbit polyclonal anti-Lamin B1 (ab16048) (Abcam Inc.) (1/900), and mouse monoclonal anti-H3K9me2 (ab1220) (Abcam Inc.) (1/800). The secondary antibodies used were rhodamine-conjugated F(ab′)2 fragment of goat anti-rabbit IgG (Jackson Immuno Research Laboratories, Inc.) (1/500) and Alexa Fluor 633-conjugated F(ab′)2 fragment of goat anti-mouse IgG (Molecular Probes, Inc.) (1/500). The samples were visualized on a Zeiss LSM 510 META Confocal Microscope with a ×63 objective.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A